|Age:||18 years and older|
|Keywords:||Scalp psoriasis, Tildrakizumab|
|Type:||Phase 3, Drug Study|
Signup to learn more!
Other eligibility criteria will be determined during the initial clinic visit.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.